IMGN-779 shows a significant therapeutic approach in the leukemia landscape. This unique naked antibody selectively binds to CD33, an antigen present by a significant portion of acute myeloid leukemia. Compared to https://www.targetmol.com/compound/anti_cd33_antibody__imgn_779_naked_antibody_